This website was discontinued on 20/12/2022. Visit the new website at www.fct.pt.
The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Novel Mitochondrial Mechanisms of Doxorubicin-induced Selective Cardiotoxicity. Paulo Jorge Gouveia Simoes Da Silva Oliveira, Centro de Neurociências e Biologia Celular (CNBC/UC). €115,800.
Growth factors in health and disease. Maria João Gameiro de Mascarenhas Saraiva, Instituto de Biologia Molecular e Celular (IBMC/UP). €173,897.
Diabetes and the somatosensory system: effects of dysfunctions in insulin and its related peptides in painful diabetic neuropathy. Isaura Ferreira Tavares, Faculdade de Medicina da Universidade do Porto (FM/UP). €92,324.
Disruption of hepatic glucose and lipid metabolism by immunosuppressive agents: implications for diagnosis and treatment of posttransplant diabetes. John Griffith Jones, Centro de Neurociências e Biologia Celular (CNBC/UC). €152,223.
Bone marrow derived cell therapy for diabetes-associated erectile dysfunction. Carla Sofia Rodrigues da Costa, Faculdade de Medicina da Universidade do Porto (FM/UP). €111,362.
Nutraceuticals: a shield against chronic disease? -contribution for the rationale of a new therapeutic option-. António José Murinello de Sousa Guerreiro, Pró-INSA, Associação para a Promoção da Investigação em Saúde (Pró-INSA/INSARJ). €170,000.
A new route for endothelial dysfunction on diabetes: From phenotypes to molecules. Henrique Girao, Associação para a Investigação Biomédica e Inovação em Luz e Imagem (AIBILI). €170,795.
Metabolic activity and viability of chondrocytes in cryopreserved human osteochondral allografts. Maria Celeste Fernandes Lopes, Centro de Neurociências e Biologia Celular (CNBC/UC). €81,864.
Changes in gastro-intestinal hormones after weight loss induced by bariatric surgery with gastric banding. Maria Helena Cardoso Pereira da Silva, Instituto de Ciências Biomédicas Abel Salazar da universidade do Porto (ICBAS/UP). €198,884.
Towards the establishment of cell-based therapy for repairing cardiac-injury: characterization, purification and functional analysis of potential therapeutic-beneficial cell-subsets. Perpetua Pinto do Ó, Instituto de Biologia Molecular e Celular (IBMC/UP). €193,228.
Rationale and options in dietary use of canned sardines in olive oil and tomato (omega 3, lycopene, and oleic acid) related to inflammatory and aterotrombogenic biomarkers in obesity and metabolic syndrome related cardiovascular disease. Pedro Orlando Rodrigues, Faculdade de Ciências Médicas (FCM/UNL). €179,738.
Disturbance of the physiologic pathways and molecular mechanisms regulating energy homeostasis in obesity and metabolic syndrome: searching new strategies and therapeutic targets. Carlos Palmeira, Centro de Neurociências e Biologia Celular (CNBC/UC). €156,000.
Validation of a predictive model to estimate the risk of conversion to clinically significant macular edema and/or vision loss in mild nonproliferative diabetic retinopathy in diabetes type 2. José Cunha-Vaz, Associação para a Investigação Biomédica e Inovação em Luz e Imagem (AIBILI). €80,987.
FIBRINOGEN-DEPENDENT SIGNALLING IN MICROVASCULAR BLOOD CELL FUNCTION - IMPLICATIONS OF INFLAMMATION AND CARDIOVASCULAR DISEASE. Maria Carlota Saldanha Lopes, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €101,736.
ORIGIN AND FATE OF EXTRACELLULAR PURINES REGULATING HUMAN BONE FORMATION. Paulo Correia de Sá, Instituto de Ciências Biomédicas Abel Salazar da universidade do Porto (ICBAS/UP). €85,324.